COVID-19 is the disease caused by infection with the SARS-CoV-2 virus. Since it emerged at the end of 2019, the virus has caused a global pandemic. Vaccination against COVID-19 has brought hope, but has also raised questions. ...
Feb 9, 2022
0
0
A research team led by Professor Jun Takahashi and Assistant Professor Asuka Morizane at the Center for iPS Cell Research and Application (CiRA) at Kyoto University, Japan, has carried out a study to compare the impact of ...
Sep 26, 2013
0
0
(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.
May 15, 2013
0
0
There are currently no licensed vaccines available for COVID-19. While several antiviral drugs have been tested, none has proved to be completely effective against the disease. In a study just published in the journal MDPI ...
Jun 10, 2020
0
2
New research shows that an enzyme that has long been considered relatively useless to the immune response instead has an important role in setting up immune cells to kill infection-causing bacteria.
Jun 11, 2012
0
0
A commonly used drug called fluvoxamine was recently tested as a treatment for COVID-19 in the United States. The 152 patients enrolled in the trial had been confirmed to have COVID-19 using a PCR test, and had seen symptoms ...
Nov 30, 2020
0
11
Health workers may soon have a new weapon in the fight against abscesses—difficult-to-treat bacterial infections that lead to millions of emergency-room visits every year.
Sep 28, 2016
0
1
EPFL start-up Anokion has the immune system in its sights. The company has developed technology for retraining white blood cells that holds promise for treating autoimmune, allergic, and a number of other diseases. A group ...
May 5, 2014
0
0
Researchers have discovered a mechanism for COVID-19 susceptibility using a newly created tool. The tool, GASPACHO, captures dynamic changes in gene expression along the innate immune response, allowing researchers to identify ...
Jun 15, 2023
0
28
(Medical Xpress)—Researchers at Moffitt Cancer Center and colleagues at the University of South Florida; Duke University; Johns Hopkins University; the Brazilian National Cancer Institute; and the Rio de Janeiro Federal ...
Oct 16, 2012
0
0
